pre-IPO PHARMA

COMPANY OVERVIEW

Phanes Therapeutics is an innovative drug discovery company that develops therapies to treat solid tumors and eye diseases. At Phanes, we believe that strong science is the basis for innovation and only people with passion and resilience can deliver ground-breaking results. Through innovation, we aim to solve some of the most difficult scientific problems in the biopharma industry. Our goal is to become an important source of innovative molecules and deliver some of the most robust therapies to improve patients’ lives.


LOCATION

  • San Diego, CA, USA

  • THERAPEUTIC AREAS

  • Oncology
  • Ophthalmology

  • WEBSITE

    https://www.phanesthera.com


    CAREER WEBSITE

    https://www.phanesthera.com/careers


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Sep 14, 2023

    Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board


    Sep 7, 2023

    Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT217 for Small Cell Lung Cancer and Other Neuroendocrine Cancers Expressing DLL3


    Sep 5, 2023

    Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board


    May 30, 2023

    Phanes Therapeutics announces the appointment of Rita Laeufle, MD, PhD, as Chief Medical Officer


    Mar 20, 2023

    Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT886 for Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinomas


    For More Press Releases


    Google Analytics Alternative